872047-63-7 Usage
Uses
Used in Medicinal Chemistry:
Benzo[d]oxazol-6-ylMethanaMine is used as a chemical intermediate for the synthesis of various pharmaceutical compounds, leveraging its unique structural features to enhance drug properties such as potency, selectivity, and bioavailability.
Used in Drug Development:
In the pharmaceutical industry, benzo[d]oxazol-6-ylMethanaMine is utilized as a key component in the development of novel therapeutic agents targeting a range of diseases. Its incorporation into drug molecules can potentially improve their pharmacokinetic and pharmacodynamic profiles, leading to more effective treatments.
Used in Research and Development:
Benzo[d]oxazol-6-ylMethanaMine serves as a valuable tool in academic and industrial research settings, where it is employed to explore new chemical space and investigate the structure-activity relationships of potential drug candidates. Its unique properties make it a promising scaffold for the design of innovative therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 872047-63-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,2,0,4 and 7 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 872047-63:
(8*8)+(7*7)+(6*2)+(5*0)+(4*4)+(3*7)+(2*6)+(1*3)=177
177 % 10 = 7
So 872047-63-7 is a valid CAS Registry Number.
872047-63-7Relevant academic research and scientific papers
Multicyclic bis-amide MMP inhibitors
-
Page/Page column 98, (2008/06/13)
The present invention relates generally to bis-amide group containing pharmaceutical agents, and in particular, to multicyclic bis-amide MMP-13 inhibitor compounds. More particularly, the present invention provides a new class of MMP-13 inhibiting compounds, containing a pyrimidinyl bis-amide group in combination with a heterocyclic moiety, that exhibit an increased potency and solubility in relation to currently known bis-amide group containing MMP-13 inhibitors.
